Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study
Conclusions: Our findings suggest potential benefits of statins on improving survival among elderly PDAC patients; further prospective studies are warranted to corroborate the putative benefit of statin therapy in pancreatic cancer.
Impact: Although more studies are needed to confirm our findings, our data add to the body of evidence on potential anticancer effects of statins. Cancer Epidemiol Biomarkers Prev; 26(8); 1225–32. ©2017 AACR.
Source: Cancer Epidemiology Biomarkers and Prevention - Category: Cancer & Oncology Authors: E, J.-Y., Lu, S.-E., Lin, Y., Graber, J. M., Rotter, D., Zhang, L., Petersen, G. M., Demissie, K., Lu-Yao, G., Tan, X.-L. Tags: Research Articles Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Cholesterol | Databases & Libraries | Epidemiology | Fortamet | Medicare | Metformin | Pancreas | Pancreatic Cancer | Statin Therapy | Study